Gene-microbiota interactions contribute to the pathogenesis of inflammatory bowel disease
Open accessThe DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Abstract
Genes and microbes converge in colitis: Both host genetics and intestinal microbes probably contribute to a person's overall susceptibility to inflammatory bowel disease (IBD). The human gut microbe Bacteroides fragilis produces immunomodulatory molecules that it releases via outer membrane vesicles (OMVs). These molecules can protect mice from experimentally induced colitis. Chu et al. now find that OMV-mediated protection from colitis requires Atg16l1 and Nod2 genes whose human orthologs are associated with an increased risk for developing IBD. OMVs trigger an ATG16L1 and NOD2–dependent noncanonical autophagy pathway in dendritic cells (DCs). OMV-primed DCs, in turn, induce regulatory T cells in the intestine that protect against colitis. Science , this issue p. 1116
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“commensal Bacteroides fragilis‐induced activation of LAP drives a transcriptionally tolerogenic program of differentiation in antigen‐presenting cells, which is required to generate immunosuppressive TREG cells in the context of colitis (Chu et al, 2016).”
From Autophagy in major human diseases (2021) · cites this paper as Chu et al, 2016
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Martinez, J., Malireddi, R. K. S., Lu, Q., Cunha, L. D., Pelletier, S., Gingras, S., Orchard, R., Guan, J.-L., Tan, H., Peng, J., et al. (2015) · Nature Cell Biology · doi:10.1038/ncb3192 · Cited by 758 · cited 12×
“Data are representative of at least three independent experiments, with three to nine mice per group. a known product of LAP activation (36), but at significantly reduced levels in Nod2−/− or Tlr2−/− DCs (fig.”
BackgroundInfluentialSelf-citationRetractedGenome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls
The Wellcome Trust Case Control Consortium, Management Committee, Burton, P. R., Clayton, D. G., Cardon, L. R., Craddock, N., Deloukas, P., Duncanson, A., Kwiatkowski, D. P., McCarthy, M. I., et al. (2007) · Nature · doi:10.1038/nature05911 · Cited by 9,442
Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease
Hugot, J.-P., Chamaillard, M., Zouali, H., Lesage, S., Cézard, J.-P., Belaiche, J., Almer, S., Tysk, C., O'Morain, C. A., Gassull, M., et al. (2001) · Nature · doi:10.1038/35079107 · Cited by 5,591
Role of the microbiota in immunity and inflammation.
Belkaid, Y., & Hand, T. W. (2014) · Cell · doi:10.1016/j.cell.2014.03.011 · Cited by 5,385 · cited 2×
“Intestinal microbiota modulate development and function of the immune system, and play a critical role in inflammatory bowel disease (IBD), a family of idiopathic intestinal disorders including Crohn’s disease (CD) and ulcerative colitis (UC) (1-6).”
BackgroundA frameshift mutation in NOD2 associated with susceptibility to Crohn's disease
Ogura, Y., Bonen, D. K., Inohara, N., Nicolae, D. L., Chen, F. F., Ramos, R., Britton, H., Moran, T., Karaliuskas, R., Duerr, R. H., et al. (2001) · Nature · doi:10.1038/35079114 · Cited by 5,030
Molodecky, N. A., Soon, I. S., Rabi, D. M., Ghali, W. A., Ferris, M., Chernoff, G., Benchimol, E. I., Panaccione, R., Ghosh, S., Barkema, H. W., et al. (2012) · Gastroenterology · doi:10.1053/j.gastro.2011.10.001 · Cited by 4,833
Host–microbe interactions have shaped the genetic architecture of inflammatory bowel disease
The International IBD Genetics Consortium (IIBDGC), Jostins, L., Ripke, S., Weersma, R. K., Duerr, R. H., McGovern, D. P., Hui, K. Y., Lee, J. C., Philip Schumm, L., Sharma, Y., et al. (2012) · Nature · doi:10.1038/nature11582 · Cited by 4,722 · cited 2×
“published online EpubJan (S0016-5085(11)01378-3 [pii]10.”
Self-citationInteractions Between the Microbiota and the Immune System
Hooper, L. V., Littman, D. R., & Macpherson, A. J. (2012) · Science · doi:10.1126/science.1223490 · Cited by 4,173 · cited 2×
“Intestinal microbiota modulate development and function of the immune system, and play a critical role in inflammatory bowel disease (IBD), a family of idiopathic intestinal disorders including Crohn’s disease (CD) and ulcerative colitis (UC) (1-6).”
BackgroundAntimicrobial Autophagy: A Conserved Innate Immune Response in Drosophila
Moy, R. H., & Cherry, S. (2013) · Journal of Innate Immunity · doi:10.1159/000350326 · Cited by 3,539
A microbial symbiosis factor prevents intestinal inflammatory disease
Mazmanian, S. K., Round, J. L., & Kasper, D. L. (2008) · Nature · doi:10.1038/nature07008 · Cited by 2,340 · cited 1×
“fragilis capsular Polysaccharide A (PSA) is packaged in outer membrane vesicles (OMVs) and delivered to intestinal dendritic cells to induce interleukin-10 (IL-10) production from CD4+Foxp3+ regulatory T cells (Tregs), which protect from experimental colitis (30-32).”
BackgroundSelf-citation
Cited by
Items 101–200 of 645
Nod2: A Critical Regulator of Ileal Microbiota and Crohn’s Disease
Sidiq, T., Yoshihama, S., Downs, I., & Kobayashi, K. S. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00367 · Cited by 127
“Furthermore, a recent study showed that ATG16L1- or NOD2-deficient DCs have impaired capability to induce Tregs upon stimulation with immunomodulatory molecules from the commensal Bacteroides fragilis, indicating the immunosuppressive role of NOD2 and ATG16L1 in intestinal dendritic cells (136).”
BackgroundThe neurovascular unit and systemic biology in stroke — implications for translation and treatment
Tiedt, S., Buchan, A. M., Dichgans, M., Lizasoaín, I., Moro, M. Á., & Lo, E. H. (2022) · Nature Reviews Neurology · doi:10.1038/s41582-022-00703-z · Cited by 149
The genetic background of inflammatory bowel disease: from correlation to causality
Venema, W. T. U., Voskuil, M. D., Dijkstra, G. D. H., Weersma, R. K., & Festen, E. A. M. (2016) · The Journal of Pathology · doi:10.1002/path.4817 · Cited by 149
“ATG16L1 can limit cytokine production, and both mice and patients carrying the ATG16L1 risk variant have defective microbial clearance and altered cytokine response towards both viruses and bacteria, suggesting the involvement of host–microbe interactions [55,79,81,82,87,88].”
BackgroundLi, X., Zhang, Z., Zabed, H. M., Yun, J., Zhang, G., & Qi, X. (2021) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202000461 · Cited by 134
Fang, H., Fu, L., & Wang, J. (2018) · BioMed Research International · doi:10.1155/2018/8941340 · Cited by 123
Alemany-Cosme, E., González, E. S., Moret, I., Mateos, B., Iborra, M., Nos, P., Sandoval, J., & Beltrán, B. (2021) · Antioxidants · doi:10.3390/antiox10010064 · Cited by 148
“It was also recently reported that NOD2 and ATG16L1 might cooperate as part of a common pathway to promote anti-inflammatory immune responses to the microbiota [71].”
BackgroundAntigen-specific regulatory T-cell responses to intestinal microbiota
Russler-Germain, E. V., Rengarajan, S., & Hsieh, C.-S. (2017) · Mucosal Immunology · doi:10.1038/mi.2017.65 · Cited by 130
Gut Microbiota-Kidney Cross-Talk in Acute Kidney Injury
Gong, J., Noel, S., Pluznick, J. L., Hamad, A. R. A., & Rabb, H. (2018) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2018.10.009 · Cited by 124
Neuroimmunophysiology of the gut: advances and emerging concepts focusing on the epithelium
Sharkey, K. A., Beck, P. L., & McKay, D. M. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-018-0051-4 · Cited by 127
Long, Q., Zheng, P., Zheng, X. W., Li, W., Hua, L., Yang, Z., Huang, W., & Ma, Y. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114321 · Cited by 118
Genetic and Epigenetic Etiology of Inflammatory Bowel Disease: An Update
Jarmakiewicz-Czaja, S., Zielińska, M., Sokal-Dembowska, A., & Filip, R. (2022) · Genes · doi:10.3390/genes13122388 · Cited by 172
Conservation metagenomics: a new branch of conservation biology
Wei, F., Wu, Q., Hu, Y., Huang, G., Nie, Y., & Li, Y. (2018) · Science China Life Sciences · doi:10.1007/s11427-018-9423-3 · Cited by 133
Host immunity and cellular responses to bacterial outer membrane vesicles
Tiku, V., & Tan, M. (2021) · Trends in Immunology · doi:10.1016/j.it.2021.09.006 · Cited by 125
Early-Life Sugar Consumption Affects the Rat Microbiome Independently of Obesity
Noble, E. E., Hsu, T. M., Jones, R. B., Fodor, A. A., Goran, M. I., & Kanoski, S. E. (2016) · Journal of Nutrition · doi:10.3945/jn.116.238816 · Cited by 118
Cadwell, K., & Debnath, J. (2018) · Journal of Cell Biology · doi:10.1083/jcb.201706157 · Cited by 108
Mullaney, J. A., Stephens, J. E., Costello, M.-E., Fong, C., Geeling, B. E., Gavin, P. G., Wright, C. M., Spector, T. D., Brown, M. A., & Hamilton-Williams, E. E. (2018) · Microbiome · doi:10.1186/s40168-018-0417-4 · Cited by 109
“In other autoimmune diseases such as Crohn’s disease, specific genetic loci associated with disease susceptibility have been shown to influence the gut environment and lead to shifts in the resident microbial populations [11].”
Wegorzewska, M. M., Glowacki, R. W. P., Hsieh, S. A., Donermeyer, D. L., Hickey, C. A., Horvath, S. C., Martens, E. C., Stappenbeck, T. S., & Allen, P. M. (2019) · Science Immunology · doi:10.1126/sciimmunol.aau9079 · Cited by 107
Poillet-Perez, L., Sharp, D. W., Yang, Y., Laddha, S. V., Ibrahim, M., Bommareddy, P. K., Hu, Z. S., Vieth, J., Haas, M., Bosenberg, M. W., et al. (2020) · Nature Cancer · doi:10.1038/s43018-020-00110-7 · Cited by 107
The role of mitochondrial ROS in antibacterial immunity
Pinegin, B., Vorobjeva, N., Pashenkov, M., & Chernyak, B. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.26117 · Cited by 106
Stehlikova, Z., Kostovcik, M., Kostovcikova, K., Kverka, M., Juzlova, K., Rob, F., Hercogova, J., Bohac, P., Pinto, Y., Uzan, A., et al. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.00438 · Cited by 105
Clinical Effect of IRT-5 Probiotics on Immune Modulation of Autoimmunity or Alloimmunity in the Eye
Kim, J., Choi, S. H., Kim, Y., Jeong, H. J., Ryu, J. J., Lee, H. J., Kim, T., Im, S., Oh, J. Y., & Kim, M. (2017) · Nutrients · doi:10.3390/nu9111166 · Cited by 108
Jalanka, J., Mattila, E., Jouhten, H., Hartman, J., de Vos, W. M., Arkkila, P., & Satokari, R. (2016) · BMC Medicine · doi:10.1186/s12916-016-0698-z · Cited by 104
Oxymatrine protects against DSS-induced colitis via inhibiting the PI3K/AKT signaling pathway
Chen, Q., Duan, X., Fan, H., Xu, M., Tang, Q., Zhang, L., Shou, Z., Liu, X., Zuo, D., Yang, J., et al. (2017) · International Immunopharmacology · doi:10.1016/j.intimp.2017.10.025 · Cited by 106
Gut microbial DL-endopeptidase alleviates Crohn’s disease via the NOD2 pathway
Gao, J., Zhao, X., Hu, S., Huang, Z., Hu, M., Jin, S., Lu, B., Sun, K., Wang, Z., Fu, J., et al. (2022) · Cell Host & Microbe · doi:10.1016/j.chom.2022.08.002 · Cited by 114
Depressive symptoms in inflammatory bowel disease: an extraintestinal manifestation of inflammation?
Moulton, C. D., Pavlidis, P., Norton, C., Norton, S., Pariante, C., Hayee, B., & Powell, N. (2019) · Clinical and Experimental Immunology · doi:10.1111/cei.13276 · Cited by 101
Rubicon: LC 3‐associated phagocytosis and beyond
Wong, S., Sil, P., & Martinez, J. (2018) · The FEBS Journal · doi:10.1111/febs.14354 · Cited by 101
Therapeutic effects of lentinan on inflammatory bowel disease and colitis‐associated cancer
Liu, Y., Zhao, J., Zhao, Y., Zong, S., Tian, Y., Chen, S., Li, M., Liu, H., Zhang, Q., Jing, X.-S., et al. (2018) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13897 · Cited by 100
“immune disorders.(34) Studies have shown that polysaccharides are capable of balancing the intestinal microbiota.”
BackgroundGenetic Studies of Inflammatory Bowel Disease-Focusing on Asian Patients
Park, S. C., & Jeen, Y. T. (2019) · Cells · doi:10.3390/cells8050404 · Cited by 108
“Bacteroides fragilis produces immunomodulatory molecules such as polysaccharide A, via the outer membrane vesicles and these molecules can protect mice from colitis [92].”
BackgroundThe Impact of Intratumoral and Gastrointestinal Microbiota on Systemic Cancer Therapy
Cogdill, A. P., Gaudreau, P. O., Arora, R., Gopalakrishnan, V., & Wargo, J. A. (2018) · Trends in Immunology · doi:10.1016/j.it.2018.09.007 · Cited by 98
Polyphenols: immunonutrients tipping the balance of immunometabolism in chronic diseases
Ferreira, C., Vieira, P., Sá, H., Malva, J. O., Castelo-Branco, M. S., Reis, F., & Viana, S. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1360065 · Cited by 115
“Particularly, Autophagy Related 16 Like 1 (ATG16L1) gene de fi ciency in macrophages increases the risk of Chron ’ s Disease development (209) and suppresses DCs ’ ability to induce Treg cells in contexts of intestinal in fl ammation (210).”
BackgroundKyrmizi, I., Ferreira, H., Carvalho, A., Figueroa, J. A. L., Zarmpas, P., Cunha, C., Akoumianaki, T., Stylianou, K., Deepe, G. S., Samonis, G., et al. (2018) · Nature Microbiology · doi:10.1038/s41564-018-0167-x · Cited by 96
Spatially distinct physiology of Bacteroides fragilis within the proximal colon of gnotobiotic mice
Donaldson, G. P., Chou, W., Manson, A. L., Rogov, P., Abeel, T., Bochicchio, J., Ciulla, D., Melnikov, A., Ernst, P. B., Chu, H., et al. (2020) · Nature Microbiology · doi:10.1038/s41564-020-0683-3 · Cited by 99
Self-citationAlteration of gut microbiota induced by DPP-4i treatment improves glucose homeostasis
Liao, X., Song, L., Zeng, B., Liu, B., Qiu, Y., Qu, H., Zheng, Y., Long, M., Zhou, H., Wang, Y., et al. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2019.03.057 · Cited by 103
“Aberrant changes in the gut microbiota are associated with the occurrence and development of various diseases, such as immunological diseases [4], inflamed intestinal diseases [5], mental disorders [6], and metabolic diseases [7–10].”
BackgroundHelicobacter pylori infection is associated with an altered gastric microbiota in children
Brawner, K. M., Kumar, R., Serrano, C. A., Ptacek, T., Lefkowitz, E. J., Morrow, C. D., Zhi, D., Kyanam-Kabir-Baig, K., Smythies, L. E., Harris, P. R., et al. (2017) · Mucosal Immunology · doi:10.1038/mi.2016.131 · Cited by 100
Yang, Y., Wang, Y., Zhao, L., Wang, F., Li, M., Wang, Q., Luo, H., Zhao, Q., Zeng, J., Zhao, Y., et al. (2023) · Chinese Herbal Medicines · doi:10.1016/j.chmed.2023.03.003 · Cited by 119
Dynamics of the Stool Virome in Very Early-Onset Inflammatory Bowel Disease
Liang, G., Conrad, M. A., Kelsen, J. R., Kessler, L. R., Breton, J., Albenberg, L. G., Marakos, S., Galgano, A., Devas, N., Erlichman, J., et al. (2020) · Journal of Crohn's and Colitis · doi:10.1093/ecco-jcc/jjaa094 · Cited by 91
“[2] We analysed stool samples only—comparison of tissue samples might have allowed more sensitive detection of some viral lineages.”
MethodHost derived exosomes-pathogens interactions: Potential functions of exosomes in pathogen infection
Wang, J., Yao, Y., Chen, X., Wu, J., Gu, T., & Tang, X. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.09.174 · Cited by 91
Diling, C., Yang, X., Chaoqun, Z., Yang, J., Xiaocui, T., Jun, C., Shuai, O., & Yizhen, X. (2017) · Oncotarget · doi:10.18632/oncotarget.20689 · Cited by 96
Gastrointestinal Organoids: Understanding the Molecular Basis of the Host–Microbe Interface
Hill, D. R., & Spence, J. R. (2017) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2016.11.007 · Cited by 88
The Gut Microbiota in Inflammatory Bowel Disease
Sheehan, D., & Shanahan, F. (2017) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2016.09.011 · Cited by 102
Roles for neuronal and glial autophagy in synaptic pruning during development
Lieberman, O. J., McGuirt, A. F., Tang, G., & Sulzer, D. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2018.04.017 · Cited by 87
Yue, B., Luo, X., Yu, Z., Mani, S., Wang, Z., & Dou, W. (2019) · Microorganisms · doi:10.3390/microorganisms7100440 · Cited by 94
Olbjørn, C., Cvancarova Småstuen, M., Thiis-Evensen, E., Nakstad, B., Vatn, M. H., Jahnsen, J., Ricanek, P., Vatn, S., Moen, A. E., Tannæs, T. M., et al. (2019) · Clinical and Experimental Gastroenterology · doi:10.2147/ceg.s186235 · Cited by 85
“Introduction The pathogenesis of the inflammatory bowel diseases (IBD), Crohn’s disease (CD), and ulcerative colitis (UC) is not fully understood, but IBD is thought to occur due to an exaggerated immune response to luminal microbial contents in the gastrointestinal tract in genetically susceptible individuals.(1) A r…”
Chen, X., Li, H., Hu, X., Zhang, Y., & Zhang, S. (2019) · Chinese Medical Journal · doi:10.1097/cm9.0000000000000330 · Cited by 92
“[47,48] Wang et al[43] used metabonomics to investigate the relationship between the gut microbiota and CVD.”
BackgroundInfluentialReview article: fungal alterations in inflammatory bowel diseases
Lam, S., Zuo, T., Ho, M., Chan, F. K. L., Chan, P. K. S., & Ng, S. C. (2019) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.15523 · Cited by 91
Changes of gut microbiota reflect the severity of major depressive disorder: a cross sectional study
Hu, X., Li, Y., Wu, J., Zhang, H., Huang, Y., Tan, X., Wen, L., Zhou, X., Xie, P., Olasunkanmi, O. I., et al. (2023) · Translational Psychiatry · doi:10.1038/s41398-023-02436-z · Cited by 105
Autophagy and microbial pathogenesis
Keller, M. D., Torres, V. J., & Cadwell, K. (2020) · Cell Death and Differentiation · doi:10.1038/s41418-019-0481-8 · Cited by 89
Mancini, N. L., Goudie, L. J. L., Xu, W., Sabouny, R., Rajeev, S., Wang, A., Esquerre, N., Rajabi, A. A., Jayme, T. S., Bernardes, E. V. T., et al. (2020) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2020.04.004 · Cited by 86
“Indeed, a focus on epithelial mitochondrial dysfunction is compatible with the consensus on IBD etiology; disease occurs in genetically susceptible individuals by hyperactive immune responses triggered by environmental stimuli involving the gut microbiota.(13) In this context, mitochondria are important in the regulat…”
BackgroundSCFAs induce autophagy in intestinal epithelial cells and relieve colitis by stabilizing HIF-1α
Zhou, C., Li, L., Li, T., Sun, L., Yin, J., Guan, H., Wang, L., Zhu, H., Xu, P., Fan, X., et al. (2020) · Journal of Molecular Medicine · doi:10.1007/s00109-020-01947-2 · Cited by 96
The Role of Autophagy in Inflammatory Bowel Disease
Shao, B., Yao, Y., Zhai, J., Zhu, J.-H., Li, J., & Wu, K. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.621132 · Cited by 88
“The NLRP3 inflammasome comprises three components, including NLRP3 protein, adapter protein apoptosis associated speck-like protein (ASC), and procaspase-1 (Coll et al., 2015).”
BackgroundGut Microbiota as Regulators of Th17/Treg Balance in Patients With Myasthenia Gravis
Chen, P., & Tang, X. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.803101 · Cited by 106
“fragilis-derived PSA is recognized by dendritic cells (DCs) in the intestine, which produce IL-10, consequently promoting the production of Tregs (119).”
BackgroundBacterial Membrane Vesicles: Physiological Roles, Infection Immunology, and Applications
Gan, Y., Zhao, G., Wang, Z., Zhang, X., Wu, M. X., & Lu, M. (2023) · Advanced Science · doi:10.1002/advs.202301357 · Cited by 89
Gut biofilm forming bacteria in inflammatory bowel disease
Srivastava, A., Gupta, J. A., Kumar, S., & Kumar, A. (2017) · Microbial Pathogenesis · doi:10.1016/j.micpath.2017.09.041 · Cited by 92
Kim, S., Lee, J., Shin, S. G., Kim, J. K., Silwal, P., Kim, Y. J., Shin, N., Kim, P. S., Won, M., Lee, S., et al. (2020) · Autophagy · doi:10.1080/15548627.2020.1847460 · Cited by 81
Gut-Microbiota, and Multiple Sclerosis: Background, Evidence, and Perspectives
Altieri, C., Speranza, B., Corbo, M. R., Sinigaglia, M., & Bevilacqua, A. (2023) · Nutrients · doi:10.3390/nu15040942 · Cited by 90
Mucosal host-microbe interactions associate with clinical phenotypes in inflammatory bowel disease
Hu, S., Bourgonje, A. R., Gaćeša, R., Jansen, B. H., Björk, J. R., Bangma, A., Hidding, I. J., van Dullemen, H. M., Visschedijk, M. C., Faber, K. N., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-45855-2 · Cited by 96
Antigen Presentation in Transplantation
Alegre, M., Lakkis, F. G., & Morelli, A. E. (2016) · Trends in Immunology · doi:10.1016/j.it.2016.09.003 · Cited by 86
“As example, commensal Bacteroides fragilis OMVs deliver immune-regulatory signals to intestinal DCs that promote generation of Tregs in the intestine [27].”
BackgroundBacterial outer membrane vesicles and host cell death signaling
Dhital, S., Deo, P., Stuart, I., & Naderer, T. (2021) · Trends in Microbiology · doi:10.1016/j.tim.2021.04.003 · Cited by 85
Zheng, X., Hu, M., Zang, X., Fan, Q., Liu, Y., Che, Y., Guan, X., Hou, Y., Wang, G., & Hao, H. (2019) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2019.02.009 · Cited by 82
Shamoon, M., Martin, N. M., & O'Brien, C. L. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.104344 · Cited by 78
Horowitz, J. E., Warner, N. E., Staples, J. C., Crowley, E., Gosalia, N., Murchie, R., Hout, C. V. V., Fiedler, K. B., Welch, G., King, A. K., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-84938-8 · Cited by 83
THE INTESTINAL MICROBIOME IN HUMAN HEALTH AND DISEASE.
DuPont, H. L., Jiang, Z., Dupont, A. W., & Utay, N. S. (2020) · Transactions of the American Clinical and Climatological Association · Cited by 98
The diagnostic and prognostic potential of gut bacteria in inflammatory bowel disease
Ocansey, D. K. W., Hang, S., Yuan, X., Qian, H., Zhou, M., Olovo, C. V., Zhang, X., & Mao, F. (2023) · Gut Microbes · doi:10.1080/19490976.2023.2176118 · Cited by 75
“Interestingly, Bacteroides fragilis is previously linked to impaired bacterial tolerance handling by CD-associated genetic variation in the genes ATG16L1 and NOD2, while Bacteroides vulgatus is associated with CD pathogenesis and NOD2 host genetic variants.(11,103,104) Moreover, an increase in species of the Enterobac…”
BackgroundMicrobiota and IBD: Current knowledge and future perspectives
Foppa, C., Rizkala, T., Repici, A., Hassan, C., & Spinelli, A. (2023) · Digestive and Liver Disease · doi:10.1016/j.dld.2023.11.015 · Cited by 96
LC3-associated phagocytosis: host defense and microbial response
Upadhyay, S., & Philips, J. A. (2019) · Current Opinion in Immunology · doi:10.1016/j.coi.2019.04.012 · Cited by 83
Mehta, S., Cronkite, D. A., Basavappa, M. G., Saunders, T. L., Adiliaghdam, F., Amatullah, H., Morrison, S. A., Pagan, J. D., Anthony, R. M., Tonnerre, P., et al. (2017) · Science Immunology · doi:10.1126/sciimmunol.aag3160 · Cited by 73
Self-citationBai, L., Zhou, P., Li, D., & Ju, X. (2017) · Journal of Medical Microbiology · doi:10.1099/jmm.0.000568 · Cited by 81
“In particular, the intestinal microbiota are affected by many diseases, such as cancer (intestinal tumours and extra-intestinal tumours) [9], metabolic syndrome [10], liver disease [11], allergies [12], Clostridium difficile infection-associated diarrhoea (CDAD) [13], inflammatory bowel disease [14] and graft-versus-h…”
BackgroundMathur, R., Alam, M. M., Zhao, X., Liao, Y., Shen, J. Z., Morgan, S., Huang, T., Lee, H., Lee, E. S., Huang, Y., et al. (2019) · Mucosal Immunology · doi:10.1038/s41385-019-0146-4 · Cited by 79
“65 Pharmacological inhibition of autophagy was reported to up-regulate the expression of IL-23 in cultured macrophages, 66 but it remains unclear if such regulation has any role in intestinal fibrosis.”
Ligeon, L., Pena-Francesch, M., Vanoaica, L. D., Núñez, N. G., Talwar, D., Dick, T. P., & Münz, C. (2021) · Nature Communications · doi:10.1038/s41467-021-21829-6 · Cited by 79
Mechanisms and function of autophagy in intestinal disease
Lassen, K. G., & Xavier, R. J. (2018) · Autophagy · doi:10.1080/15548627.2017.1389358 · Cited by 82
Self-citationJang, K. K., Heaney, T., London, M., Ding, Y., Putzel, G., Yeung, F., Ercelen, D., Chen, Y.-H., Axelrad, J., Gurunathan, S., et al. (2023) · Cell Host & Microbe · doi:10.1016/j.chom.2023.08.002 · Cited by 70
Yan, X., Yang, C., Yang, M., Ma, Y., Zhang, Y., Zhang, Y., Liu, C., Xu, Q., Tu, K., & Zhang, M. (2022) · Journal of Nanobiotechnology · doi:10.1186/s12951-022-01299-8 · Cited by 72
Yang, Y., Zheng, X., Wang, Y., Tan, X., Zou, H., Feng, S., Zhang, H., Zhang, Z., He, J., Cui, B., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.836542 · Cited by 88
“org 2 The intestinal microbiota is involved in immune system development and other processes, and imbalance in intestinal microecology is closely associated with the occurrence and development of a variety of human diseases (11), including IBD (12).”
BackgroundProssomariti, A., Scaioli, E., Piazzi, G., Fazio, C., Bellanova, M., Biagi, E., Candela, M., Brigidi, P., Consolandi, C., Balbi, T., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-07992-1 · Cited by 75
FXR mediates ILC-intrinsic responses to intestinal inflammation
Fu, T., Li, Y., Oh, T. G., Cayabyab, F., He, N., Tang, Q., Coulter, S., Truitt, M., Medina, P., He, M., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2213041119 · Cited by 75
Ji, J., Ge, X., Chen, Y., Zhu, B., Wu, Q., Zhang, J., Shan, J., Cheng, H., & Shi, L. (2019) · The FASEB Journal · doi:10.1096/fj.201802659rr · Cited by 69
“has indicated that the dysbiosis of gut microbiota and sustained inflammation and injury are implicated in the pathogenesis of IBDs (3).”
BackgroundInfluentialStrain diversity in the microbiome: Lessons from Bacteroides fragilis
Carrow, H. C., Batachari, L. E., & Chu, H. (2020) · PLoS Pathogens · doi:10.1371/journal.ppat.1009056 · Cited by 73
“fragilis NCTC 9343 expresses PSA, which drives regulatory T cells to produce interleukin-10, an anti-inflammatory cytokine responsible for maintaining immune tolerance [22,25].”
BackgroundSelf-citationShen, Q., Huang, Z., Ma, L., Yao, J., Luo, T., Zhao, Y., Xiao, Y., & Jin, Y. (2022) · Gut Microbes · doi:10.1080/19490976.2022.2128604 · Cited by 71
“Abundant evidence has proven that BMVs are involved in interactions between host and gut microbes and maintaining intestinal homeostasis.(22,23) Currently, EVs-based treatment has developed as an advanced therapeutic approach for various diseases.”
BackgroundThe Microbiome in Crohn's Disease
Khanna, S., & Raffals, L. E. (2017) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2017.05.004 · Cited by 109
A Bioinspired Versatile Spore Coat Nanomaterial for Oral Probiotics Delivery
Song, Q., Zhao, H., Zheng, C., Wang, K., Gao, H., Feng, Q., Zhang, H., Zhang, Z., Zhang, Y., & Wang, L. (2021) · Advanced Functional Materials · doi:10.1002/adfm.202104994 · Cited by 66
Lynch, J. B., & Alegado, R. ʻ. (2017) · Journal of Bacteriology · doi:10.1128/jb.00012-17 · Cited by 67
A ravenous defense: canonical and non-canonical autophagy in immunity
Sil, P., Muse, G. W., & Martinez, J. (2017) · Current Opinion in Immunology · doi:10.1016/j.coi.2017.10.004 · Cited by 69
Deficiency in intestinal epithelial O‐GlcNAcylation predisposes to gut inflammation
Zhao, M., Xiong, X., Ren, K., Xu, B., Cheng, M., Sahu, C., Wu, K., Nie, Y., Huang, Z., Blumberg, R. S., et al. (2018) · EMBO Molecular Medicine · doi:10.15252/emmm.201708736 · Cited by 70
“Mounting evidence suggests that IBD-associated mutations in autophagy-related genes impair Paneth cell function (Cadwell et al, 2009; Henckaerts et al, 2011; Patel & Stappenbeck, 2013; Chu et al, 2016).”
BackgroundImmunomodulatory roles and novel applications of bacterial membrane vesicles
Gilmore, W. J., Johnston, E. L., Zavan, L., Bitto, N. J., & Kaparakis‐Liaskos, M. (2021) · Molecular Immunology · doi:10.1016/j.molimm.2021.02.027 · Cited by 66
Dong, Y., Cheng, H., Liu, Y., Xue, M., & Liang, H. W. (2019) · Food & Function · doi:10.1039/c9fo00583h · Cited by 71
An overview of the bacterial contribution to Crohn disease pathogenesis
Alhagamhmad, M. H., Day, A. S., Lemberg, D. A., & Leach, S. T. (2016) · Journal of Medical Microbiology · doi:10.1099/jmm.0.000331 · Cited by 71
“…immune response There is a consensus that interaction of several putative factors, including microbial, genetic and environment, contributes to loss of mucosal homeostasis, the subsequent provocation of the mucosal immune system and development of CD (Chu et al., 2016; Lewis et al., 2015) (Fig.”
Ertürk-Hasdemir, D., & Kasper, D. L. (2018) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.13660 · Cited by 74
Ma, Y., Hu, C., Yan, W., Jiang, H., & Liu, G. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.591408 · Cited by 67
Jin, G., Tang, Q., Ma, J., Liu, X., Zhou, B., Sun, Y., Pang, X., Guo, Z., Xie, R., Liu, T., et al. (2021) · mSystems · doi:10.1128/msystems.01337-20 · Cited by 62
Emerging role of bacterial outer membrane vesicle in gastrointestinal tract
Tian, C., Yang, M., Xu, H., Zhu, M., Zhang, Y., Yao, J., Wang, L., Liang, Y.-J., & Li, D. (2023) · Gut Pathogens · doi:10.1186/s13099-023-00543-2 · Cited by 67
He, Q., Niu, M., Bi, J., Du, N., Liu, S., Yang, K., Li, H., Yao, J., Du, Y., & Duan, Y. (2023) · Scientific Reports · doi:10.1038/s41598-023-42481-8 · Cited by 74
“IL-10 is an anti-inflammatory cytokine, IL-10 knockout mice could spontaneously develop colonic inflammation, which is accompanied by increased intestinal permeability and various pro-inflammatory cytokines 41,42 .”
ATG16L1 functions in cell homeostasis beyond autophagy
Hamaoui, D., & Subtil, A. (2021) · FEBS Journal · doi:10.1111/febs.15833 · Cited by 64
Impact of Autophagy of Innate Immune Cells on Inflammatory Bowel Disease
Iida, T., Yokoyama, Y., Wagatsuma, K., Hirayama, D., & Nakase, H. (2018) · Cells · doi:10.3390/cells8010007 · Cited by 64
Gut Microbiota Modulation as a Novel Therapeutic Strategy in Cardiometabolic Diseases
Mutalub, Y. B., Abdulwahab, M., Mohammed, A., Yahkub, A. M., Al-Mhanna, S. B., Yusof, W., Tang, S. P., Rasool, A. H. G., & Mokhtar, S. S. (2022) · Foods · doi:10.3390/foods11172575 · Cited by 72
Omics and Multi-Omics in IBD: No Integration, No Breakthroughs
Fiocchi, C. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241914912 · Cited by 68
“While enlightening and exciting, all results of microbiomics reports must be interpreted with caution in view of the extensive impact of genetics [60], lifestyle [61], nutrition [62], immunity [63], common drugs or drugs used to treat IBD patients [38,64] on gut microbiota composition and function.”
BackgroundChen, Y., Shui, M., Li, H., Guo, M., Yuan, Q., Hao, W., Wang, T., Zhou, H., Chen, Z., & Wang, S. (2025) · Biomaterials · doi:10.1016/j.biomaterials.2025.123163 · Cited by 68
Krautkramer, K. A., Dhillon, R. S., Denu, J. M., & Carey, H. V. (2017) · Translational research · doi:10.1016/j.trsl.2017.08.005 · Cited by 63
Fecal microbiota transplantation for Crohn’s disease: a systematic review and meta-analysis
Cheng, F., Huang, Z., Wei, W., & Li, Z. (2021) · Techniques in Coloproctology · doi:10.1007/s10151-020-02395-3 · Cited by 67
Uncoupling of IL-6 signaling and LC3-associated phagocytosis drives immunoparalysis during sepsis
Akoumianaki, T., Vaporidi, K., Diamantaki, E., Pène, F., Beau, R., Gresnigt, M. S., Gkountzinopulou, M., Venichaki, M., Drakos, E., Benna, J. E., et al. (2021) · Cell Host & Microbe · doi:10.1016/j.chom.2021.06.002 · Cited by 63
Gilmore, W. J., Johnston, E. L., Bitto, N. J., Zavan, L., O’brien-simpson, N. M., Hill, A. F., & Kaparakis‐Liaskos, M. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.970725 · Cited by 66
“fragilis OMVs contain PSA and can modulate host immunity, as a result of TLR2 activation and the secretion of IL-10, to ultimately confer protection against colitis in murine models of disease (22, 25).”
BackgroundInfluential
Metadata
- Authors
- Chu, H., Khosravi, A., Kusumawardhani, I. P., Kwon, A. H. K., Vasconcelos, A. C., Cunha, L. D., Mayer, A. E., Shen, Y., Wu, W.-L., Kambal, A., Targan, S. R., Xavier, R. J., Ernst, P. B., Green, D. R., McGovern, D. P. B., Virgin, H. W., & Mazmanian, S. K.
- Affiliations
- California Institute of Technology (US)
- University of California San Diego (US)
- St. Jude Children's Research Hospital (US)
- Washington University in St. Louis (US)
- Cedars-Sinai Medical Center (US)
- Harvard University (US)
- Corresponding author
- Chu, Hiutung
- Mazmanian, Sarkis K.
- ORCID
- Venue
- Science
- Published
- 2016-05-27
- Volume
- 352
- Issue
- 6289
- Pages
- 1116-1120
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- PMC
- PMC4996125
- OpenAlex
- W2346233234
- Cited by
- 647
- References
- 48
- Citations by year
- 2026: 50 · 2025: 55 · 2024: 60 · 2023: 64 · 2022: 57 · 2021: 69 · 2020: 68 · 2019: 77 · 2018: 56 · 2017: 65 · 2016: 24
- FWCI
- 59.72
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- CaltechAUTHORS (California Institute of Technology) (submittedVersion)
- Funders
- National Institutes of Health (NIH)
- Ruth L. Kirschtein National Research Service Award (DK100109)
- Cedars-Sinai F. Widjaja Foundation Inflammatory Bowel and Immunobiology Research Institute Research Funds
- Feintech Family Chair
- Wayne and Gladys Valley Foundation
- Lupus Research Institute
- Lisa Z. Greer Endowed Chair
- European Union (305479)
- Leona M. and Harry B. Helmsley Charitable Trust
- NIH (DK097485, PO1DK046763, AI079145, AI40646, U19 AI109725, DK062413, DE023789-01, AI109725, DK078938, GM099535)
- Crohn's and Colitis Foundation of America
- Heritage Medical Research Institute
- Topics
- Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Keywords
- inflammatory bowel disease, Bacteroides fragilis, outer membrane vesicles, ATG16L1, NOD2, non-canonical autophagy, dendritic cells, regulatory T cells, colitis, gut dysbiosis, susceptibility genes, mucosal inflammation
- MeSH terms
- Extracellular Vesicles, Gastrointestinal Microbiome, Autophagy-Related Proteins, Adult, Aged, Animals, Autophagy, Bacteroides fragilis, Carrier Proteins, Dendritic Cells, Female, Humans, Intestinal Mucosa, Male, Mice, Inbred C57BL, Middle Aged, Polymorphism, Genetic, Inflammatory Bowel Diseases, Genome, Human, Genetic Predisposition to Disease, T-Lymphocytes, Regulatory, Mice, Nod2 Signaling Adaptor Protein, Gene-Environment Interaction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.